Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study-Reference-Cited by-同舟云学术

Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study

Published:2023-07 Issue: Volume:Volume 19 Page:1711-1723
ISSN:1178-2021
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

Ye JiaYi,Wei YanYan,Zeng JiaHui,Gao YuQing,Tang XiaoChen,Xu LiHua,Hu YeGang,Liu XiaoHua,Liu HaiChun,Chen Tao,Li ChunBo,Zeng LingYun,Wang JiJun,Zhang TianHong^ORCID

Publisher

Informa UK Limited

Reference53 articles.

1. GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137–150. doi:10.1016/S2215-0366(21)00395-3

2. Schizophrenia

3. Pharmacological interventions for prevention of weight gain in people with schizophrenia

4. Editorial: Early Intervention in Psychotic Disorders

5. Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased serum VEGF and NRG1β1 levels in male patients with chronic schizophrenia: VEGF correlation with clinical symptoms and cognitive deficits;Journal of Psychiatric Research;2024-08

2. Function and mechanism exploring of icariin in schizophrenia through network pharmacology;Brain Research;2024-07

3. Association between serum cytokines and timeframe for conversion from clinical high‐risk to psychosis;Psychiatry and Clinical Neurosciences;2024-04-09

4. A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms;Neuropsychopharmacology;2023-10-30

5. Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter];Neuropsychiatric Disease and Treatment;2023-09